These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 47003)

  • 1. Letter: Immunostimulants in primary hepatomas.
    Ton-that-Tung ; Nguyen-nhu-Bang ; Nguyen-van-Van ; Ton-that-Bach ; Nguyen-dang-Tam ; Salomon JC
    Lancet; 1975 Mar; 1(7905):527-8. PubMed ID: 47003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Initial clinical experience in treating primary liver cancer with immunostimulating agents used systemically or within the tumor].
    Ton Tkhat Tung ; Nguen Nkhu Bang ; Nguen Van Van ; Ton Tkhat Bakkh ; Nguen Dang Tam
    Vestn Akad Med Nauk SSSR; 1976; (8):45-52. PubMed ID: 798441
    [No Abstract]   [Full Text] [Related]  

  • 3. Current concepts in the management of primary liver-cell carcinoma.
    Balasegaram M
    Clin Oncol; 1975 Jun; 1(2):111-20. PubMed ID: 171114
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.
    Lai EC; Choi TK; Tong SW; Ong GB; Wong J
    World J Surg; 1986 Jun; 10(3):501-9. PubMed ID: 2425500
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy for carcinoma of the liver.
    Bloomenthal ED; Spellberg MA
    Am J Gastroenterol; 1971 Oct; 56(4):334-45. PubMed ID: 4330120
    [No Abstract]   [Full Text] [Related]  

  • 6. The anti-dysrhythmic effect of Althesin.
    Cundy JM
    Anaesthesia; 1973 Sep; 28(5):544-5. PubMed ID: 4728159
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatic disarterialization in the treatment of primary cancer of the liver].
    Ferrer R; Márquez F; Díaz Q
    Rev Esp Enferm Apar Dig; 1974 Jun; 43(5):455-60. PubMed ID: 4368146
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical treatment of primary liver cell carcinoma in China.
    Wu ZD; Xia SS; Qiu FZ
    Recent Results Cancer Res; 1986; 100():190-6. PubMed ID: 3016840
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiographic evaluation of hepatoma for surgical treatment.
    Nagasue N; Inokuchi K; Kobayashi M; Ogawa Y; Saku M
    Surg Gynecol Obstet; 1976 Aug; 143(2):184-90. PubMed ID: 181856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor embolism in the right atrium after hepatic artery ligation for hepatoma.
    Kanashima R; Nagasue N; Kobayashi M; Inokuchi K
    Jpn J Surg; 1977 Dec; 7(4):246-52. PubMed ID: 203738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete hepatic dearterialization for primary carcinoma of the liver. Report of twenty-four patients.
    Balasegaram M
    Am J Surg; 1972 Sep; 124(3):340-5. PubMed ID: 4115718
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II trial of epirubicin in hepatoma.
    Shiu W; Mok SD; O SK; Tsao SY; Woo KS; Li A; Leung N; Martin C
    Cancer Treat Rep; 1986 Aug; 70(8):1035-6. PubMed ID: 3015405
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
    Moran A; Ramos LF; Picado O; Pendola F; Sleeman D; Dudeja V; Merchant N; Yakoub D
    J Surg Oncol; 2019 Mar; 119(4):455-463. PubMed ID: 30575028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatectomy in patients with advanced hepatocellular carcinoma after hepatic artery chemotherapy/embolization or hepatic artery embolization/ligation].
    Hao CZ
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):735-7, 779. PubMed ID: 1339747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas.
    Nonami T; Isshiki K; Katoh H; Kishimoto W; Harada A; Nakao A; Takagi H
    Ann Surg; 1991 Mar; 213(3):222-6. PubMed ID: 1847795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with hepatic arterial infusions.
    Sanderson TA; McBride CM
    Tex Med; 1971 Mar; 67(3):52-6. PubMed ID: 4326061
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative occlusion of the hepatic artery with isobutyl 2-cyanoacrylate for resection of the "unresectable" hepatic tumor.
    Shermeta DW; Golladay ES; White RI
    Surgery; 1978 Mar; 83(3):319-22. PubMed ID: 204071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ligation of the hepatic artery. Results of 16 operations for malignant tumors of the liver].
    Loygue J; Huguet C; Gallot D
    Chirurgie; 1972 Oct; 98(10):593-9. PubMed ID: 4347542
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective ligation of portal vein and hepatic artery for ruptured hepatocellular carcinoma in a 13-year-old boy.
    Tanaka H; Honna T; Muto M; Fujino A; Kasahara M; Kitano Y; Kuroda T
    J Pediatr Surg; 2011 May; 46(5):973-7. PubMed ID: 21616264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.